Local progression after computed tomography-guided microwave ablation in non-small cell lung cancer patients: prediction using a nomogram model.

OBJECTIVES

To develop an effective nomogram model for predicting the local progression after computed tomography-guided microwave ablation (MWA) in non-small cell lung cancer (NSCLC) patients.

METHODS

NSCLC patients treated with MWA were randomly allocated to either the training cohort or the validation cohort (4:1). The predictors of local progression identified by univariable and multivariable analyses in the training cohort were used to develop a nomogram model. The -statistic was used to evaluate the predictive accuracy in both the training and validation cohorts.

RESULTS

A total of 304 patients (training cohort:  = 250; validation cohort:  = 54) were included in this study. The predictors selected into the nomogram for local progression included the tumor subtypes (odds ratio [OR], 2.494; 95% confidence interval [CI], 1.415-4.396,  = 0.002), vessels ≥3 mm in direct contact with tumor (OR, 2.750; 95% CI, 1.263-5.988;  = 0.011), tumor diameter (OR, 2.252; 95% CI, 1.034-4.903;  = 0.041) and location (OR, 2.442; 95% CI, 1.201-4.965;  = 0.014). The -statistic showed good predictive performance in both cohorts, with a -statistic of 0.777 (95% CI, 0.707-0.848) internally and 0.712 (95% CI, 0.570-0.855) externally (training cohort and validation cohort, respectively). The optimal cutoff value for the risk of local progression was 0.39.

CONCLUSIONS

Tumor subtypes, vessels ≥3 mm in direct contact with the tumor, tumor diameter and location were predictors of local progression after MWA in NSCLC patients. The nomogram model could effectively predict the risk of local progression after MWA. Patients showing a high risk (>0.39) on the nomogram should be monitored for local progression.